A study presented at the AACR Annual Meeting 2018 discussed preliminary data on an off-the-shelf, T-cell receptor (TCR)-less, dual-targeted...
Monday ushered in a ray of hope and promise for the lung cancer community at the AACR Annual Meeting...
As the 2018 Annual Meeting of the American Association for Cancer Research unfolded yesterday morning, the excitement among the...
A study presented in the AACR Annual Meeting 2018 Media Preview webinar, held March 15, examined closely a key...
This past year has been a year of many “firsts” for the oncology community, with several revolutionary advances in...
Pancreatic cancer is a deadly disease with a five-year survival rate of a mere 8.2 percent, according to statistics...
Several clinical trials are underway in which PARP inhibitors are being tested in breast cancers, mostly triple-negative breast cancers,...
In recent years, the U.S. Food and Drug Administration has approved immune checkpoint inhibitors, a class of immunotherapy, to...
A pair of studies published recently in journals of the American Association for Cancer Research bring to our attention...
A major objective of former Vice President Joe Biden’s National Cancer Moonshot Initiative is breaking down silos and sharing...